Founded in 1945 in France, Stago has built its entire business around hemostasis and thrombosis, becoming the world’s only pure-play company in the In Vitro Diagnostics industry dedicated to this field. Today, Stago delivers a complete diagnostic system: analyzers used in hospitals and laboratories, reagents, consumables, and services, to diagnose clotting disorders and thrombotic risk. With nearly 2,600 employees and over 20% of its workforce dedicated to R&D, Stago boasts a strong track record of innovation, selling its products across 115 countries through a network of subsidiaries and distributors.